These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 26852737)

  • 41. Transcriptionally Active Lung Microbiome and Its Association with Bacterial Biomass and Host Inflammatory Status.
    Ren L; Zhang R; Rao J; Xiao Y; Zhang Z; Yang B; Cao D; Zhong H; Ning P; Shang Y; Li M; Gao Z; Wang J
    mSystems; 2018; 3(5):. PubMed ID: 30417108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD.
    Liu H; Zheng D; Lin Y; Liu Z; Liang Z; Su J; Chen R; Zhou H; Wang Z
    Pharmacol Res; 2020 Oct; 160():105095. PubMed ID: 32730904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lung microbiology and exacerbations in COPD.
    Beasley V; Joshi PV; Singanayagam A; Molyneaux PL; Johnston SL; Mallia P
    Int J Chron Obstruct Pulmon Dis; 2012; 7():555-69. PubMed ID: 22969296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lung microbiome, gut-lung axis and chronic obstructive pulmonary disease.
    Gokulan K; Joshi M; Khare S; Bartter T
    Curr Opin Pulm Med; 2022 Mar; 28(2):134-138. PubMed ID: 34907959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing.
    Zakharkina T; Heinzel E; Koczulla RA; Greulich T; Rentz K; Pauling JK; Baumbach J; Herrmann M; Grünewald C; Dienemann H; von Müller L; Bals R
    PLoS One; 2013; 8(7):e68302. PubMed ID: 23874580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunology, genetics and microbiota in the COPD pathophysiology: potential scope for patient stratification.
    Malhotra R; Olsson H
    Expert Rev Respir Med; 2015 Apr; 9(2):153-9. PubMed ID: 25586213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative analysis of the alveolar microbiome in COPD, ECOPD, Sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures.
    Gupta S; Shariff M; Chaturvedi G; Sharma A; Goel N; Yadav M; Mortensen MS; Sørensen SJ; Mukerji M; Chauhan NS
    Sci Rep; 2021 Feb; 11(1):3963. PubMed ID: 33597669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of throat microbial flora in smokers with or without COPD.
    Diao W; Shen N; Du Y; Qian K; He B
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1933-1946. PubMed ID: 28740374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute exacerbations of COPD: risk factors for failure and relapse.
    Mantero M; Rogliani P; Di Pasquale M; Polverino E; Crisafulli E; Guerrero M; Gramegna A; Cazzola M; Blasi F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2687-2693. PubMed ID: 28932112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity.
    Chiu YC; Lee SW; Liu CW; Lin RC; Huang YC; Lan TY; Wu LS
    PLoS One; 2021; 16(4):e0249944. PubMed ID: 33836012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
    Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations.
    Huang YJ; Kim E; Cox MJ; Brodie EL; Brown R; Wiener-Kronish JP; Lynch SV
    OMICS; 2010 Feb; 14(1):9-59. PubMed ID: 20141328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting respiratory microbiomes in COPD and bronchiectasis.
    Mac Aogáin M; Tiew PY; Jaggi TK; Narayana JK; Singh S; Hansbro PM; Segal LN; Chotirmall SH
    Expert Rev Respir Med; 2024; 18(3-4):111-125. PubMed ID: 38743428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbiome in Chronic Obstructive Pulmonary Disease: Role of Natural Products Against Microbial Pathogens.
    Santoro A; Tomino C; Prinzi G; Cardaci V; Fini M; Macera L; Russo P; Maggi F
    Curr Med Chem; 2020; 27(18):2931-2948. PubMed ID: 31838985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
    Pragman AA; Knutson KA; Gould TJ; Isaacson RE; Reilly CS; Wendt CH
    Respir Res; 2019 Jun; 20(1):114. PubMed ID: 31174538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The sputum microbiome is distinct between COPD and health, independent of smoking history.
    Haldar K; George L; Wang Z; Mistry V; Ramsheh MY; Free RC; John C; Reeve NF; Miller BE; Tal-Singer R; Webb AJ; Brookes AJ; Tobin MD; Singh D; Donaldson GC; Wedzicha JA; Brown JR; Barer MR; Brightling CE
    Respir Res; 2020 Jul; 21(1):183. PubMed ID: 32664956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.
    Einarsson GG; Comer DM; McIlreavey L; Parkhill J; Ennis M; Tunney MM; Elborn JS
    Thorax; 2016 Sep; 71(9):795-803. PubMed ID: 27146202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease.
    Pragman AA; Lyu T; Baller JA; Gould TJ; Kelly RF; Reilly CS; Isaacson RE; Wendt CH
    Microbiome; 2018 Jan; 6(1):7. PubMed ID: 29316977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The bronchial epithelial cell bacterial microbiome and host response in patients infected with human immunodeficiency virus.
    Sze MA; Xu S; Leung JM; Vucic EA; Shaipanich T; Moghadam A; Harris M; Guillemi S; Sinha S; Nislow C; Murphy D; Hague C; Leipsic J; Lam S; Lam W; Montaner JS; Sin DD; Man SF
    BMC Pulm Med; 2016 Nov; 16(1):142. PubMed ID: 27829448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
    Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
    Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.